| |
Purification and characterization of native human insulin-like growth factor binding protein-6
- 作者:Andrea Taferner (1)
Lucia Micutkova (1) Martin Hermann (2) Pidder Jansen-Dürr (1) Haymo Pircher (1)
- 关键词:IGF ; binding protein ; Purification ; Chromatography ; Cellular uptake
- 刊名:Journal of Cell Communication and Signaling
- 出版年:2011
- 出版时间:December 2011
- 年:2011
- 卷:5
- 期:4
- 页码:277-289
- 全文大小:633KB
- 参考文献:1. Baxter RC (2000) Insulin-like growth factor (IGF)-binding proteins: interactions with IGFs and intrinsic bioactivities. Am J Physiol Endocrinol Metab 278:E967–E976
2. Butt AJ, Dickson KA, McDougall F, Baxter RC (2003) Insulin-like growth factor-binding protein-5 inhibits the growth of human breast cancer cells in vitro and in vivo. J Biol Chem 278:29676-9685 CrossRef 3. Cerro JA, Grewal A, Wood TL, Pintar JE (1993) Tissue-specific expression of the insulin-like growth factor binding protein (IGFBP) mRNAs in mouse and rat development. Regul Pept 48:189-98 CrossRef 4. Chen Z, Chen H, Wang X, Ma X, Huang B (2007) Expression, purification, and characterization of secreted recombinant human insulin-like growth factor-binding protein-6 in methylotrophic yeast Pichia pastoris. Protein Expr Purif 52:239-48 CrossRef 5. Dailly YP, Zhou Y, Linkhart TA, Baylink DJ, Strong DD (2001) Structure and characterization of the human insulin-like growth factor binding protein (IGFBP)-6 promoter: identification of a functional retinoid response element. Biochim Biophys Acta 1518:145-51 6. Firth SM, Baxter RC (2002) Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev 23:824-54 CrossRef 7. Foulstone E, Prince S, Zaccheo O, Burns JL, Harper J, Jacobs C, Church D, Hassan AB (2005) Insulin-like growth factor ligands, receptors, and binding proteins in cancer. J Pathol 205:145-53 CrossRef 8. Fowlkes JL, Thrailkill KM, George-Nascimento C, Rosenberg CK, Serra DM (1997) Heparin-binding, highly basic regions within the thyroglobulin type-1 repeat of insulin-like growth factor (IGF)-binding proteins (IGFBPs) ?, ?, and ? inhibit IGFBP-4 degradation. Endocrinology 138:2280-285 CrossRef 9. Fu P, Thompson JA, Bach LA (2007) Promotion of cancer cell migration: an insulin-like growth factor (IGF)-independent action of IGF-binding protein-6. J Biol Chem 282:22298-2306 CrossRef 10. Fu P, Liang GJ, Khot SS, Phan R, Bach LA (2010) Cross-talk between MAP kinase pathways is involved in IGF-independent, IGFBP-6-induced Rh30 rhabdomyosarcoma cell migration. J Cell Physiol 224:636-43 CrossRef 11. Gallicchio MA, Kneen M, Hall C, Scott AM, Bach LA (2001) Overexpression of insulin-like growth factor binding protein-6 inhibits rhabdomyosarcoma growth in vivo. Int J Cancer 94:645-51 CrossRef 12. Goda N, Tenno T, Inomata K, Shirakawa M, Tanaka T, Hiroaki H (2008) Intracellular protein delivery activity of peptides derived from insulin-like growth factor binding proteins 3 and 5. Exp Cell Res 314:2352-361 CrossRef 13. Grellier P, De Galle B, Babajko S (1998) Expression of insulin-like growth factor-binding protein 6 complementary DNA alters neuroblastoma cell growth. Cancer Res 58:1670-676 14. Headey SJ, Leeding KS, Norton RS, Bach LA (2004) Contributions of the N- and C-terminal domains of IGF binding protein-6 to IGF binding. J Mol Endocrinol 33:377-86 CrossRef 15. Holbourn KP, Acharya KR, Perbal B (2008) The CCN family of proteins: structure-function relationships. Trends Biochem Sci 33:461-73 CrossRef 16. Hong J, Zhang G, Dong F, Rechler MM (2002) Insulin-like growth factor (IGF)-binding protein-3 mutants that do not bind IGF-I or IGF-II stimulate apoptosis in human prostate cancer cells. J Biol Chem 277:10489-0497 CrossRef 17. Hwa V, Oh Y, Rosenfeld RG (1999) The insulin-like growth factor-binding protein (IGFBP) superfamily. Endocr Rev 20:761-87 CrossRef 18. Iosef C, Gkourasas T, Jia CY, Li SS, Han VK (2008) A functional nuclear localization signal in insulin-like growth factor binding protein-6 mediates its nuclear import. Endocrinology 149:1214-226 CrossRef 19. Iosef C, Vilk G, Gkourasas T, Lee KJ, Chen BP, Fu P, Bach LA, Lajoie G, Gupta MB, Li SS, Han VK (2010) Insulin-like growth factor binding protein-6 (IGFBP-6) interacts with DNA-end binding protein Ku80 to regulate cell fate. Cell Signal 22:1033-043 CrossRef 20. Kim HS, Nagalla SR, Oh Y, Wilson E, Roberts CT Jr, Rosenfeld RG (1997) Identification of a family of low-affinity insulin-like growth factor binding proteins (IGFBPs): characterization of connective tissue growth factor as a member of the IGFBP superfamily. Proc Natl Acad Sci USA 94:12981-2986 CrossRef 21. Kim EJ, Kang YH, Schaffer BS, Bach LA, MacDonald RG, Park JH (2002) Inhibition of Caco-2 cell proliferation by all-trans retinoic acid: role of insulin-like growth factor binding protein-6. J Cell Physiol 190:92-00 CrossRef 22. Kuo YS, Tang YB, Lu TY, Wu HC, Lin CT (2010) IGFBP-6 plays a role as an oncosuppressor gene in NPC pathogenesis through regulating EGR-1 expression. J Pathol 222:299-09 CrossRef 23. Lee KW, Liu B, Ma L, Li H, Bang P, Koeffler HP, Cohen P (2004) Cellular internalization of insulin-like growth factor binding protein-3: distinct endocytic pathways facilitate re-uptake and nuclear localization. J Biol Chem 279:469-76 CrossRef 24. Liu B, Lee KW, Li H, Ma L, Lin GL, Chandraratna RA, Cohen P (2005) Combination therapy of insulin-like growth factor binding protein-3 and retinoid X receptor ligands synergize on prostate cancer cell apoptosis in vitro and in vivo. Clin Cancer Res 11:4851-856 CrossRef 25. Martin JL, Willetts KE, Baxter RC (1990) Purification and properties of a novel insulin-like growth factor-II binding protein from transformed human fibroblasts. J Biol Chem 265:4124-130 26. Neumann GM, Marinaro JA, Bach LA (1998) Identification of O-glycosylation sites and partial characterization of carbohydrate structure and disulfide linkages of human insulin-like growth factor binding protein 6. Biochemistry 37:6572-585 CrossRef 27. Perbal B (2004) CCN proteins: multifunctional signalling regulators. Lancet 363:62-4 CrossRef 28. Pircher H, Matscheski A, Laich A, Hermann M, Moser B, Viertler HP, Micutkova L, Lindner H, Sarg B, Zwerschke W, Jansen-Durr P (2010) A new method for the purification of bioactive insulin-like growth factor-binding protein-3. Protein Expr Purif 71:160-67 CrossRef 29. Rabut G, Doye V, Ellenberg J (2004) Mapping the dynamic organization of the nuclear pore complex inside single living cells. Nat Cell Biol 6:1114-121 CrossRef 30. Schedlich LJ, Le Page SL, Firth SM, Briggs LJ, Jans DA, Baxter RC (2000) Nuclear import of insulin-like growth factor-binding protein-3 and ? is mediated by the importin beta subunit. J Biol Chem 275:23462-3470 CrossRef 31. Srinivasan N, Edwall D, Linkhart TA, Baylink DJ, Mohan S (1996) Insulin-like growth factor-binding protein-6 produced by human PC-3 prostate cancer cells: isolation, characterization and its biological action. J Endocrinol 149:297-03 CrossRef 32. Sueoka N, Lee HY, Wiehle S, Cristiano RJ, Fang B, Ji L, Roth JA, Hong WK, Cohen P, Kurie JM (2000) Insulin-like growth factor binding protein-6 activates programmed cell death in non-small cell lung cancer cells. Oncogene 19:4432-436 CrossRef 33. Wagner M, Hampel B, Bernhard D, Hala M, Zwerschke W, Jansen-Durr P (2001) Replicative senescence of human endothelial cells in vitro involves G1 arrest, polyploidization and senescence-associated apoptosis. Exp Gerontol 36:1327-347 CrossRef 34. Weber MM, Spottl G, Gossl C, Engelhardt D (1999) Characterization of human insulin-like growth factor-binding proteins by two-dimensional polyacrylamide gel electrophoresis and Western ligand blot analysis. J Clin Endocrinol Metab 84:1679-684 CrossRef 35. Xu XF, Guo CY, Liu J, Yang WJ, Xia YJ, Xu L, Yu YC, Wang XP (2009) Gli1 maintains cell survival by up-regulating IGFBP6 and Bcl-2 through promoter regions in parallel manner in pancreatic cancer cells. J Carcinog 8:13 CrossRef
- 作者单位:Andrea Taferner (1)
Lucia Micutkova (1) Martin Hermann (2) Pidder Jansen-Dürr (1) Haymo Pircher (1)
1. Institute for Biomedical Aging Research, Austrian Academy of Sciences, Rennweg 10, 6020, Innsbruck, Austria 2. KMT Laboratory, Department of Visceral, Transplant and Thoracic Surgery, Center of Operative Medicine, Innsbruck Medical University, Innrain 66, 6020, Innsbruck, Austria
文摘
Insulin-like growth factor binding proteins (IGFBPs) are key regulators of insulin-like growth factor (IGF) mediated signal transduction and thereby can profoundly influence cellular phenotypes and cell fate. Whereas IGFBPs are extracellular proteins, intracellular activities were described for several IGFBP family members, such as IGFBP-3, which can be reinternalized by endocytosis and reaches the nucleus through routes that remain to be fully established. Within the family of IGFBPs, IGFBP-6 is unique for its specific binding to IGF-II. IGFBP-6 was described to possess additional IGF-independent activities, which have in part been attributed to its translocation to the nucleus; however, cellular uptake of IGFBP-6 was not described. To further explore IGFBP-6 functions, we developed a new method for the purification of native human IGFBP-6 from cell culture supernatants, involving a four-step affinity purification procedure, which yields highly enriched IGFBP-6. Whereas protein purified in this way retained the capacity to interact with IGF-II and modulate IGF-dependent signal transduction, our data suggest that, unlike IGFBP-3, human IGFBP-6 is not readily internalized by human tumor cells. To summarize, this work describes a novel and efficient method for the purification of native human insulin-like growth factor binding protein 6 (IGFBP-6) from human cell culture supernatants, applying a four-step chromatography procedure. Intactness of purified IGFBP-6 was confirmed by IGF ligand Western blot and ability to modulate IGF-dependent signal transduction. Cellular uptake studies were performed to further characterize the purified protein, showing no short-term uptake of IGFBP-6, in contrast to IGFBP-3.
| |
NGLC 2004-2010.National Geological Library of China All Rights Reserved.
Add:29 Xueyuan Rd,Haidian District,Beijing,PRC. Mail Add: 8324 mailbox 100083
For exchange or info please contact us via email.
| |